Yet since 2010, when the Social Security Trust Fund first started running a cash deficit, budget negotiators have repeatedly attempted to enact Social Security reforms that would decrease benefits. One of the most widely - discussed proposals would switch to a more slowly - growing inflation measure — the chained consumer price index (CPI) — to calculate the annual cost – of – living adjustment as a means of slowing the growth of Social Security benefits and other inflation - adjusted federal programs. Although the proposal was not adopted in the past, primarily due to fear of public backlash, "It remains a key feature in many plans for reducing the deficit," Johnson says. .Johnson cautions, "The current inflationary trend may only be temporary, because prices today are compared with a big sudden drop in prices a year ago when the impact of COVID-19 first began to hit our economy." "The jump we see now is centered primarily on energy prices, but a number of other spending categories have stayed relatively flat," she says. .Last year President Trump proposed lowering the prices of certain Medicare drug prices by tying those prices to lower prices paid in other developed countries. Under that proposal, prices would have been lower than they are now, but would still be a certain percentage higher than they are in other countries. The President was not satisfied with that idea, according to Health and Human Services Secretary Alex Azar. On Wednesday Azar said the President wants the proposal changed so that prices in the United States are even lower than they are in other countries. .The first new rule affects Medicare Part B drug costs, which are typically infused or injected drugs used mainly in the treatment of cancer. The intent is to cap the cost of those drugs at the lowest price that drug manufacturers receive in other countries and to pay doctors a flat fee for each dose of a drug, instead of a percentage of each drug's cost. .Thousands of The Senior Citizens League's supporters – including the 800 petition signers – have told us they are failing to keep up with rising costs, and they are forced every day to make tough decisions about how they will spend their Social Security checks. To address this growing issue, The Senior Citizens League and its supporters urge Congress to adopt the Social Security Expansion Act (S. 427) before the end of the 115th Congress. .The FDA is particularly concerned that these deceptive and misleading products might cause Americans to delay or stop appropriate medical treatment, leading to serious and life-threatening harm. It's likely that the products do not do what they claim, and the ingredients in them could cause adverse effects and could interact with, and potentially interfere with, essential medications. .How To Grow Your Initial Retirement Benefit By 8% Per Year Until Age 70. If you have the choice, learn how delaying your retirement benefit can result in a higher benefit and pay a return today's CDs and most bonds can't touch. .In addition, eleven new cosponsors signed on to the Preventing and Reducing Improper Medicare and Medicaid Expenditures (PRIME) Act (S. 1123 and H.R. 2305) this week, bringing the total up to seventeen in the Senate and nineteen in the House. If signed into law, the bill would take a number of steps to prevent fraud, waste, and abuse within the two programs. It would enact stronger penalties, curb mistaken payments, phase out the "pay and chase" method, reduce physician identity theft, and improve data-sharing, among other things. The new cosponsors are Sens. Joe Manchin (WV) and Mike Johanns (NE), and Reps. Tim Griffin (AR-2), Diane Black (TN-6), Tammy Duckworth (IL-8), Ed Whitfield (KY-1), Reid Ribble (WI-8), Steve Womack (AR-3), Julia Brownley (CA-26), Tom Latham (IA-3), and Markwayne Mullin (OK-2). ."The Congressional Budget Office said in 2019 that the bill would likely hamper some pharmaceutical development due to lower ‘potential global revenues' but predicted that ‘the effects of the new drug introductions from increased federal spending under the bill on biomedical research would be modest and would almost all occur more than 20 years in the future.' On the other hand, it estimated that the bill would save more than 0 billion in drug spending over the next decade."